4//SEC Filing
Bellevue Global Life Science Investors LLC 4
Accession 0000898432-23-000167
CIK 0001840425other
Filed
Mar 26, 8:00 PM ET
Accepted
Mar 27, 4:03 PM ET
Size
7.7 KB
Accession
0000898432-23-000167
Insider Transaction Report
Form 4
Transactions
- Other
Warrant for Common Stock
2023-03-23−20,000→ 370,000 totalExercise: $11.50→ Common Stock (20,000 underlying) - Other
Common Stock
2023-03-23−20,000→ 2,000,500 total
Footnotes (3)
- [F1]Represents shares of common stock held by Bellevue Global Life Sciences Investors LLC, the sponsor of the Issuer (the "Sponsor") whose general partner is Bellevue Capital Management LLC ("Bellevue Capital"). Kuk Hyoun Hwang is the managing partner of Bellevue Capital and has voting and dispositive power over the shares held by the Sponsor.
- [F2]Represents the shares transferred by the Sponsor to Mr. David Jin Yoo for service as Chief Financial Officer.
- [F3]Represents the warrant to purchase a total of 20,000 shares of the Issuer, transferred from the Sponsor to Mr. David Jin Yoo for his service as Chief Financial Officer. Each warrant will become exercisable 30 days after the Issuer's initial business combination. Each warrant will expire five years after the completion of the Issuer's initial business combination, or earlier upon redemption or liquidation. Each warrant entitles the holder to purchase one share of common stock at a price of $11.50 per share, subject to adjustments.
Documents
Issuer
Bellevue Life Sciences Acquisition Corp.
CIK 0001840425
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001953768
Filing Metadata
- Form type
- 4
- Filed
- Mar 26, 8:00 PM ET
- Accepted
- Mar 27, 4:03 PM ET
- Size
- 7.7 KB